SE9501056D0 - Epithelial adherent lactobacilli - Google Patents

Epithelial adherent lactobacilli

Info

Publication number
SE9501056D0
SE9501056D0 SE9501056A SE9501056A SE9501056D0 SE 9501056 D0 SE9501056 D0 SE 9501056D0 SE 9501056 A SE9501056 A SE 9501056A SE 9501056 A SE9501056 A SE 9501056A SE 9501056 D0 SE9501056 D0 SE 9501056D0
Authority
SE
Sweden
Prior art keywords
pct
mannose
date sep
sec
strain
Prior art date
Application number
SE9501056A
Other languages
English (en)
Swedish (sv)
Inventor
Ingegerd Adlerberth
Siv Ahrne
Bengt Jeppson
Marie-Louise Johansson
Goeran Molin
Agnes Wold
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Priority to SE9501056A priority Critical patent/SE9501056D0/xx
Publication of SE9501056D0 publication Critical patent/SE9501056D0/xx
Priority to EE9700329A priority patent/EE04097B1/xx
Priority to AU51665/96A priority patent/AU702705B2/en
Priority to AT96908428T priority patent/ATE240738T1/de
Priority to BR9607538A priority patent/BR9607538A/pt
Priority to PCT/SE1996/000372 priority patent/WO1996029083A1/en
Priority to ES96908428T priority patent/ES2200057T3/es
Priority to DE69628288T priority patent/DE69628288T2/de
Priority to US08/913,618 priority patent/US6159465A/en
Priority to CNB961940867A priority patent/CN1138551C/zh
Priority to PL96322550A priority patent/PL184037B1/pl
Priority to CA002216150A priority patent/CA2216150C/en
Priority to HK98111312.1A priority patent/HK1017989B/xx
Priority to JP52834796A priority patent/JP4072646B2/ja
Priority to EP96908428A priority patent/EP0817640B1/en
Priority to KR1019970706504A priority patent/KR100446482B1/ko
Priority to NO974371A priority patent/NO974371L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Adhesives Or Adhesive Processes (AREA)
SE9501056A 1995-03-23 1995-03-23 Epithelial adherent lactobacilli SE9501056D0 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli
KR1019970706504A KR100446482B1 (ko) 1995-03-23 1996-03-25 상피흡착성락토바실러스
ES96908428T ES2200057T3 (es) 1995-03-23 1996-03-25 Uso de lactobacillus como adhesivo epitelial.
US08/913,618 US6159465A (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
AT96908428T ATE240738T1 (de) 1995-03-23 1996-03-25 Verwendung von epithel-adhärente lactobazillen
BR9607538A BR9607538A (pt) 1995-03-23 1996-03-25 Lactobacilos aderentes ao epitélio
PCT/SE1996/000372 WO1996029083A1 (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
EE9700329A EE04097B1 (et) 1995-03-23 1996-03-25 Epiteliaal-adhesiivsed laktobatsillid
DE69628288T DE69628288T2 (de) 1995-03-23 1996-03-25 Verwendung von epithel-adhärente lactobazillen
AU51665/96A AU702705B2 (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
CNB961940867A CN1138551C (zh) 1995-03-23 1996-03-25 上皮粘附性乳杆菌
PL96322550A PL184037B1 (pl) 1995-03-23 1996-03-25 Zastosowanie Lactobacillus plantarum
CA002216150A CA2216150C (en) 1995-03-23 1996-03-25 Epithelial adhesive lactobacilli
HK98111312.1A HK1017989B (zh) 1995-03-23 1996-03-25 上皮粘附性乳杆菌
JP52834796A JP4072646B2 (ja) 1995-03-23 1996-03-25 上皮接着性乳酸桿菌
EP96908428A EP0817640B1 (en) 1995-03-23 1996-03-25 Use of epithelial adhesive lactobacilli
NO974371A NO974371L (no) 1995-03-23 1997-09-22 Epitelialadhesive lactobacilli

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli

Publications (1)

Publication Number Publication Date
SE9501056D0 true SE9501056D0 (sv) 1995-03-23

Family

ID=20397666

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9501056A SE9501056D0 (sv) 1995-03-23 1995-03-23 Epithelial adherent lactobacilli

Country Status (16)

Country Link
US (1) US6159465A (https=)
EP (1) EP0817640B1 (https=)
JP (1) JP4072646B2 (https=)
KR (1) KR100446482B1 (https=)
CN (1) CN1138551C (https=)
AT (1) ATE240738T1 (https=)
AU (1) AU702705B2 (https=)
BR (1) BR9607538A (https=)
CA (1) CA2216150C (https=)
DE (1) DE69628288T2 (https=)
EE (1) EE04097B1 (https=)
ES (1) ES2200057T3 (https=)
NO (1) NO974371L (https=)
PL (1) PL184037B1 (https=)
SE (1) SE9501056D0 (https=)
WO (1) WO1996029083A1 (https=)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100376954B1 (ko) * 1995-07-31 2003-07-18 프로비 에이비 장에서집락화하는유산간균
ES2168785T5 (es) * 1997-07-05 2009-04-16 Societe Des Produits Nestle S.A. Absorcion de minerales por las celulas intestinales.
FI974643A7 (fi) * 1997-12-30 1999-07-01 Suomen Rehu Oy Biologinen menetelmä salmonellan eliminoimiseksi prosesseista ja rakenteista
KR20010075495A (ko) * 1998-10-01 2001-08-09 추후보정 산화성 스트레스 인자의 감소
WO2001010448A1 (en) * 1999-08-09 2001-02-15 University Of Maryland, Baltimore Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
MXPA02004115A (es) 1999-10-26 2002-10-17 Nestle Sa Bacterias acidolacticas para el tratamiento o profilaxis de giardiasis.
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
SE0004124D0 (sv) * 2000-11-10 2000-11-10 Probi Ab New use
FR2831555A1 (fr) * 2001-10-29 2003-05-02 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
FR2826020B1 (fr) * 2001-06-14 2005-02-11 Ceva Sante Animale Procede de selection de souches de bacteries lactiques a gram positif non pathogenes capables de lutter contre des infections par des bacteries pathogenes
PL364429A1 (en) * 2001-06-14 2004-12-13 Ceva Sante Animale Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2005086870A2 (en) * 2004-03-10 2005-09-22 The Board Of Trustees Of The University Of Illinois Novel lactobacillus strains and method of use
JP2007530034A (ja) * 2004-03-23 2007-11-01 エヌ．ブイ．・ヌートリシア 新規のマンノース特異的アドヘシンとその使用
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP2006180836A (ja) * 2004-12-28 2006-07-13 Marudai Food Co Ltd 食中毒菌感染を抑制する乳酸菌、ならびにそれを含む発酵物、食品および医薬組成物
JP2006257077A (ja) * 2005-02-18 2006-09-28 Marudai Food Co Ltd 免疫調節剤および免疫調節食品
CN1888051B (zh) * 2005-06-28 2010-05-05 北京天佑达生物工程科技有限公司 一株植物乳杆菌及其应用
SE529199C2 (sv) * 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption
DK3067057T3 (da) * 2005-09-28 2023-02-13 Nordic Rebalance As Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
DK1960016T3 (en) 2005-12-13 2017-01-09 Exthera Medical Corp Method for extracorporeal removal by a pathogenic MI-KROBE, an inflammatory cell or inflammatory protein from the blood.
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
FR2928935B1 (fr) 2008-03-19 2011-05-20 Gervais Danone Sa Souche de lactobacillus rhamnosus.
EP2459203B1 (en) * 2009-07-30 2018-10-31 DuPont Nutrition Biosciences ApS Lactic acid bacteria and bifidobacteria for treating endotoxemia
EP2509604B1 (en) 2009-12-01 2021-03-17 ExThera Medical Corporation Device for removing cytokines from blood with surface immobilized polysaccharides
ES2437940T3 (es) 2010-01-28 2014-01-15 Ab-Biotics S.A. Composición probiótica para uso en el tratamiento de la inflamación del intestino
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
BG66608B1 (bg) * 2011-05-04 2017-10-16 "Ел Би Булгарикум" ЕАД Полибактериален пробиотичен препарат
CN102618456B (zh) * 2012-02-28 2013-08-21 江南大学 一种能够缓解慢性酒精性肝损伤的鼠李糖乳杆菌及其用途
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
JP2012184261A (ja) * 2012-06-21 2012-09-27 Snow Brand Milk Products Co Ltd 免疫増強剤
CN102827796B (zh) * 2012-09-03 2013-10-30 江南大学 一种具有排镉功能的植物乳杆菌及其用途
EP2897638A1 (en) 2012-09-24 2015-07-29 Montana State University-Bozeman Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use
MX376935B (es) 2013-06-24 2025-03-07 Exthera Medical Corp Sistema de filtración de sangre que contiene substrato recubierto con manosa.
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
AU2015250107A1 (en) 2014-04-24 2016-11-17 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
KR102587444B1 (ko) 2015-09-29 2023-10-11 킴벌리-클라크 월드와이드, 인크. 미생물총의 건강한 균형을 유지하기 위한 상승 조성물
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
MX389431B (es) 2017-02-28 2025-03-20 Kimberly Clark Co Composicion sinergica para el mantenimiento del equilibrio saludable de la microflora.
KR102024883B1 (ko) 2017-11-24 2019-09-24 주식회사 고바이오랩 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
SG10202112104UA (en) 2018-05-09 2021-12-30 Ko Biolabs Inc Lactobacillus paracasei strain and use thereof
AU2019274351B2 (en) 2018-05-23 2022-04-07 Kobiolabs, Inc. Lactobacillus gasseri KBL697 strain and use thereof
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
CN114007434A (zh) 2019-06-05 2022-02-01 森永乳业株式会社 营养组合物
CN111575223B (zh) * 2020-05-20 2022-04-15 江南大学 一种降低鼠李糖乳杆菌表面物质分泌量的方法
CN119242500A (zh) * 2024-09-30 2025-01-03 尚品健康科技(青岛)有限公司 一株母乳来源植物乳植杆菌改善过敏性疾病和调节肠道菌群的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR861387B (en) * 1985-05-29 1986-10-02 Pioneer Hi Bred Int Method of treating gastrointestinal disease in animals
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
GB9124249D0 (en) * 1991-11-14 1992-01-08 Goldstein Fredric Ribbon curling and shredding device
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection

Also Published As

Publication number Publication date
US6159465A (en) 2000-12-12
JPH11502703A (ja) 1999-03-09
DE69628288D1 (de) 2003-06-26
DE69628288T2 (de) 2004-04-08
KR19980703102A (ko) 1998-10-15
KR100446482B1 (ko) 2006-01-27
ES2200057T3 (es) 2004-03-01
CA2216150C (en) 2008-01-22
PL322550A1 (en) 1998-02-02
CN1185111A (zh) 1998-06-17
EP0817640B1 (en) 2003-05-21
HK1017989A1 (en) 1999-12-10
ATE240738T1 (de) 2003-06-15
CA2216150A1 (en) 1996-09-26
JP4072646B2 (ja) 2008-04-09
NO974371D0 (no) 1997-09-22
EE04097B1 (et) 2003-08-15
EE9700329A (et) 1998-06-15
AU5166596A (en) 1996-10-08
EP0817640A1 (en) 1998-01-14
WO1996029083A1 (en) 1996-09-26
CN1138551C (zh) 2004-02-18
AU702705B2 (en) 1999-03-04
BR9607538A (pt) 1998-01-06
PL184037B1 (pl) 2002-08-30
NO974371L (no) 1997-11-20

Similar Documents

Publication Publication Date Title
SE9501056D0 (sv) Epithelial adherent lactobacilli
Blum et al. Adhesion studies for probiotics: need for validation and refinement
Chauvière et al. Adhesion of human Lactobacillus acidophilus strain LB to human enterocyte-like Caco-2 cells
Ogawa et al. Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA
Jensen et al. In vitro testing of commercial and potential probiotic lactic acid bacteria
Pithva et al. Probiotic attributes of autochthonous Lactobacillus rhamnosus strains of human origin
TR200101699T2 (tr) Urogenital enfeksiyonların önlenmesi ve tedavisi için ağızdan lactobakilus uygulaması
Delley et al. In vitro activity of commercial probiotic Lactobacillus strains against uropathogenic Escherichia coli
AU6040001A (en) Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
EA200101262A1 (ru) Диетическая или фармацевтическая композиция для применения в целях профилактики или лечения гипероксалурии
HUP9901619A1 (hu) Streptococcus thermophilus és bifidobacterium longum baktériumokat tartalmazó enterális diétás kompozíciók és azok alkalmazása
Neilands et al. Parvimonas micra stimulates expression of gingipains from Porphyromonas gingivalis in multi-species communities
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
NO975136D0 (no) Farmasöytisk blanding omfattende Lactobacillus plantarum og arginin
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
Henriksson et al. Adhesion of Lactobacillus fermentum 104-S to porcine stomach mucus
DK0858501T3 (da) Mælkesyrebakteriepræparater samt deres anvendelse til fremstilling af kolesterolsænkende produkter
Iwamoto et al. The Japanese fermented food natto inhibits sucrose-dependent biofilm formation by cariogenic streptococci
AU5069500A (en) Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels
Hryniewicz et al. The first national external quality assessment scheme in clinical bacteriology in Poland(POLMicro I)
LeVatte Repression of the Pseudomonas aeruginosa ferripyochelin-binding protein expression by subinhibitory concentrations of antibiotics
GEP20033132B (en) Bacteriological Preparations
UA23320A (uk) Штам бактерій віfіdовастеrіuм lоnguм, який використовується у виробhицтві бактеріальhих препаратів та фермеhтоваhих молочhих продуктів